Recent work by Li et al. identifying adipogenin as a structural cofactor of seipin introduces a new paradigm in lipid droplet (LD) biology, shifting attention from enzymatic control of lipid synthesis toward organelle architecture as a determinant of metabolic disease. This evidence concerns the gene ADIG and Other metabolic disease.